Literature DB >> 24790516

Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Alper Karalok1, Işın Ureyen1, Yıldız Reis1, Ozge Oktay1, Taner Turan1, Nurettin Boran1, Dilek Bülbül2, Gökhan Tulunay1, Mehmet Faruk Köse1.   

Abstract

OBJECTIVE: To investigate the likelihood of the detection of the necessity of staging preoperatively with the use of clinical parameters and frozen/section (FS).
MATERIAL AND METHODS: 219 patients were included who were operated on between 1996 and 2010 with a diagnosis of grade 1 endometrioid adenocarcinoma in probe curettage.
RESULTS: Among the clinical characteristics, only age and body mass index (BMI) predicted staging preoperatively. The probability of staging increased as age increased and BMI decreased. The concordance between preoperative diagnosis and FS was 89.5%. The diagnosis was upgraded at postoperative evaluation for 13 patients (5.9%), and downgraded for 2 patients (0.9%) compared with FS. The wrong diagnosis regarding grade, the depth of myometrial invasion DMI, tumour type and cervical invasion in FS was clinically significant and affected the decision of staging in 10 patients. In conclusion, only 7 patients (3.2%) who acquired staging surgery were missed in FS.
CONCLUSION: It was shown that preoperative clinical parameters could not effectively predict the patients who should be staged. FS predicted the lymphatic involvement with high accuracy. The patient with a preoperative diagnosis of grade 1 endometrium cancer should be operated upon in centres where FS is utilised and oncologic staging surgery can be performed.

Entities:  

Keywords:  Endometrial cancer; age; body mass index; frozen/section; staging

Year:  2014        PMID: 24790516      PMCID: PMC4004303          DOI: 10.5152/jtgga.2013.79803

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  41 in total

1.  Predictors of final histology in patients with endometrial cancer.

Authors:  Michael Frumovitz; Diljeet K Singh; Larissa Meyer; Daniel H Smith; Iris Wertheim; Ephraim Resnik; Diane C Bodurka
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

2.  Intraoperative evaluation of prognostic factors in stage I endometrial cancer by frozen section: how reliable?

Authors:  C G Zorlu; E Kuscu; Y Ergun; T Aydogdu; O Cobanoglu; O Erdas
Journal:  Acta Obstet Gynecol Scand       Date:  1993-07       Impact factor: 3.636

3.  Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.

Authors:  Chuyao Zhang; Chao Wang; Weiwei Feng
Journal:  Int J Gynecol Cancer       Date:  2012-10       Impact factor: 3.437

4.  Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.

Authors:  James C Pavelka; Inbar Ben-Shachar; Jeffrey M Fowler; Nilsa C Ramirez; Larry J Copeland; Lynne A Eaton; Tom P Manolitsas; David E Cohn
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

5.  Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study.

Authors:  R C Boronow; C P Morrow; W T Creasman; P J Disaia; S G Silverberg; A Miller; J A Blessing
Journal:  Obstet Gynecol       Date:  1984-06       Impact factor: 7.661

6.  The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

Authors:  John K Chan; Huahsi Wu; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Daniel S Kapp
Journal:  Gynecol Oncol       Date:  2007-08       Impact factor: 5.482

7.  Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma.

Authors:  J Fanning; Y Tsukada; M S Piver
Journal:  Gynecol Oncol       Date:  1990-04       Impact factor: 5.482

8.  The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Authors:  E Everett; H Tamimi; B Greer; E Swisher; P Paley; L Mandel; B Goff
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

9.  The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.

Authors:  P Y Roland; F J Kelly; C Y Kulwicki; P Blitzer; M Curcio; J W Orr
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  2 in total

Review 1.  The Multifunctional Faces of T-Cell Intracellular Antigen 1 in Health and Disease.

Authors:  Andrea Fernández-Gómez; José M Izquierdo
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

2.  Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience.

Authors:  A Santoro; A Piermattei; F Inzani; G Angelico; M Valente; D Arciuolo; S Spadola; M Martini; F Fanfani; A Fagotti; V Gallotta; G Scambia; G F Zannoni
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.